GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for TIPS-2

TIPS-2

Official Title

The evaluation of the Polycap in two doses

Status

Completed

Overview

To evaluate full daily doses of the components of the Polycap in 518 subjects with stable CVD or elevated risk factors. Participants were randomized to single dose Polycap (half dose; as in TIPS-1) or two doses of the Polycap (full dose).

Study Design

Randomized, double-blind.

Number of Patients

2053

Number of Sites

53

Number of Countries

1

Study Period

2010–2010

Principal Investigator

Salim Yusuf

Program Manager

Jackie Bosch

Collaborators

Cadila

Key Publications

  • Yusuf S, Pais P, Sigamani A, et al. Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (Polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators. Circ Cardiovasc Qual Outcomes. Jul 1 2012;5(4):463-471.